Skip to content
10-Q

Quarterly Report

Gossamer Bio, Inc. GOSS

0001728117-25-000036

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 227.3M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $29.02M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $46.07M
Current Liabilities Q1 2025 · Mar 31, 2025 $48.22M
Current Liabilities Q1 2025 · Dec 31, 2024 $45.01M
Total Liabilities Q1 2025 · Mar 31, 2025 $286.84M
Total Liabilities Q1 2025 · Dec 31, 2024 $285.8M
Current Assets Q1 2025 · Mar 31, 2025 $275.48M
Current Assets Q1 2025 · Dec 31, 2024 $309.89M
Total Assets Q1 2025 · Mar 31, 2025 $280.59M
Total Assets Q1 2025 · Dec 31, 2024 $315.29M
Shares Diluted Q1 2025 · Mar 31, 2024 225.74M sh
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$52.3M
Stockholders Equity Q1 2025 · Mar 31, 2024 $26.72M
Stockholders Equity Q1 2025 · Dec 31, 2023 $62.77M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.19
Eps Basic Q1 2025 · Mar 31, 2024 −$0.19
Sga Expense Q1 2025 · Mar 31, 2024 $9.57M
Net Income Q1 2025 · Mar 31, 2024 −$41.93M
Operating Income Q1 2025 · Mar 31, 2024 −$41.96M
Revenue Q1 2025 · Mar 31, 2024 $0